| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/31/2001 | CA2055612C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus |
| 07/31/2001 | CA2024667C Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma |
| 07/31/2001 | CA2018511C Process for the preparation of purified albumin solutions |
| 07/28/2001 | CA2331674A1 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same |
| 07/27/2001 | CA2332657A1 A method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
| 07/26/2001 | WO2001053538A2 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease |
| 07/26/2001 | WO2001053531A2 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells |
| 07/26/2001 | WO2001053515A1 Methods and materials relating to novel interleukin-1 receptor-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053514A1 Toxicant-induced differential gene expression |
| 07/26/2001 | WO2001053500A1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 07/26/2001 | WO2001053499A1 Novel polypeptide---human proliferating-cell nucleolar protein 18 and polynucleotide encoding it |
| 07/26/2001 | WO2001053498A1 Novel polypeptide-ef-chiral calcium-binding protein 42 and polynucleotide encoding it |
| 07/26/2001 | WO2001053497A1 Novel polypeptide---human zinc finger protein 57 containing bola structural domain and polynucleotide encoding it |
| 07/26/2001 | WO2001053496A1 Novel polypeptide---human sodium neuro:transmitter cotransporter protein 8,43 and polynucleotide encoding it |
| 07/26/2001 | WO2001053495A1 Novel polypeptide--- a human iron sulphur protein 10 and polynucleotide encoding it |
| 07/26/2001 | WO2001053494A2 Cloning and overexpression vanadium bromoperoxidase from marine algae |
| 07/26/2001 | WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | WO2001053489A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2001053488A2 Transcription factors regulating sp-10 gene expression |
| 07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | WO2001053485A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053484A1 Wt1-interacting protein wtip |
| 07/26/2001 | WO2001053483A1 A novel polypeptide, a human zinc finger protein 30 and the polynucleotide encoding the polypeptide |
| 07/26/2001 | WO2001053480A1 Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules |
| 07/26/2001 | WO2001053479A2 Molecular switches ii |
| 07/26/2001 | WO2001053477A1 Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
| 07/26/2001 | WO2001053475A2 Isolation and characterization of a n. crassa silencing gene and uses thereof |
| 07/26/2001 | WO2001053472A2 Tumor and senescence marker |
| 07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 07/26/2001 | WO2001053466A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053458A2 Methods and reagents for performing antimicrobial compound screening |
| 07/26/2001 | WO2001053456A2 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053455A2 Novel nucleic acids and polypeptides |
| 07/26/2001 | WO2001053454A2 Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053453A2 Novel bone marrow nucleic acids and polypeptides |
| 07/26/2001 | WO2001053354A2 Methods for treating tumors using a fusion protein comprising il-2- polypeptides and p185-specific binding molecules |
| 07/26/2001 | WO2001053352A2 Sperm specific proteins |
| 07/26/2001 | WO2001053351A2 Apoptin bindendes protein |
| 07/26/2001 | WO2001053350A1 Myostatin and mimetics thereof |
| 07/26/2001 | WO2001053349A2 Small cell lung cancer associated antigens and uses therefor |
| 07/26/2001 | WO2001053348A2 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 07/26/2001 | WO2001053347A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | WO2001053346A1 Human cystine knot polypeptide |
| 07/26/2001 | WO2001053345A1 Vegf148 isoform, a truncated splice variant of vegf. vegf heterodimers and therapeutical uses thereof |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053342A1 Chimeric prostate-homing peptides with pro-apoptotic activity |
| 07/26/2001 | WO2001053341A1 A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it |
| 07/26/2001 | WO2001053340A2 Transgenic mouse model of human neurodegenerative disease |
| 07/26/2001 | WO2001053339A2 Egg specific surface proteins |
| 07/26/2001 | WO2001053338A2 Cbp86, a sperm specific protein |
| 07/26/2001 | WO2001053337A1 Human 7 transmembrane receptor axor33 |
| 07/26/2001 | WO2001053336A1 Clostridial toxin derivatives and methods for treating pain |
| 07/26/2001 | WO2001053335A2 Peptides with antibacterial activity |
| 07/26/2001 | WO2001053334A1 thdF |
| 07/26/2001 | WO2001053333A1 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 07/26/2001 | WO2001053329A1 Process for the purification of antithrombin-iii |
| 07/26/2001 | WO2001053328A1 Process for the purification of antothrombin-iii |
| 07/26/2001 | WO2001053327A2 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001053319A1 Plant oil gland nucleic acid molecules and methods of use |
| 07/26/2001 | WO2001053312A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | WO2001053308A1 Cloning of a monkey 7tm receptor (axor8) |
| 07/26/2001 | WO2001052900A2 Novel orthogonally protected amino acid chelators for biomedical applications |
| 07/26/2001 | WO2001052887A2 Vaccination against canine herpesvirus infection and vaccines |
| 07/26/2001 | WO2001052886A1 Prime-boost vaccination strategy |
| 07/26/2001 | WO2001052880A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | WO2001052875A1 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 07/26/2001 | WO2001052791A2 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 07/26/2001 | WO2001052789A2 PAX8-PPARη NUCLEIC ACID MOLECULES AND POLYPEPTIDES AND USES THEREOF |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001052643A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor |
| 07/26/2001 | WO2001052641A1 Non-human mammal with a modified glucocorticoid receptor and a modified c-fos |
| 07/26/2001 | WO2001052620A2 Methods and compositions to modulate expression in plants |
| 07/26/2001 | WO2001052616A2 Novel nucleic acids and polypeptides |
| 07/26/2001 | WO2001018212A3 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 07/26/2001 | WO2001017543A3 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 07/26/2001 | WO2001016291A3 07cg27 gene |
| 07/26/2001 | WO2001014886A3 Inhibitors of binding between proteins and macromolecular ligands |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby |
| 07/26/2001 | WO2001007566A3 Phage-resistant microorganisms and genetic determinants of phage resistance |
| 07/26/2001 | WO2001005997A3 Method for production of tetanus toxin using media substantially free of animal products |
| 07/26/2001 | WO2001004285A3 Maize msi polynucleotides and methods of use |
| 07/26/2001 | WO2001004283A3 Organic anion transporter genes and proteins |
| 07/26/2001 | WO2001004264A3 Atherosclerosis-associated genes |
| 07/26/2001 | WO2001004148A9 Donor strand complemented pilin and adhesin broad-based vaccines |
| 07/26/2001 | WO2001002601A3 Cell-based assay systems for examining hcv ns3 protease activity |
| 07/26/2001 | WO2001001748A3 Peptide compounds that bind her2 |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000078803A3 Use of eif4e binding agents in therapy |
| 07/26/2001 | WO2000078799A3 Mlo-genes controlling diseases |
| 07/26/2001 | WO2000075336A3 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines |
| 07/26/2001 | WO2000075324A9 Recombinant prion-like genes and proteins and materials and methods comprising same |
| 07/26/2001 | WO2000075180A3 Peptides for vaccinating against human cmv |
| 07/26/2001 | WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 07/26/2001 | WO2000066156A8 Death domain containing receptor 5 |
| 07/26/2001 | WO2000065037A3 Maize npr1 polynucleotides and methods of use |
| 07/26/2001 | WO2000060079A9 New members of tnf and tnfr families |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |